Moderna Vaccine Blocks 72% of Delta Variant with First Dose... "Prevents 96% of Hospitalization and Death" (Update)

Phase 3 Clinical Trial Results for 30,420 Participants Show 94.1% Effectiveness in Preventing COVID-19

[Image source=Yonhap News]

[Asia Economy Reporter Kim Ji-hee] Moderna's COVID-19 vaccine has been shown to provide 72% effectiveness against the Delta variant with just the first dose.

On the 22nd, according to the COVID-19 Vaccination Response Promotion Team (Promotion Team), Moderna's vaccine demonstrated 94.1% effectiveness in a Phase 3 clinical trial involving 30,420 participants. Additionally, in Canada, after administering the first dose to 421,073 people, the vaccine's effectiveness against variants was confirmed as 83% for the Alpha variant, 77% for the Beta and Gamma variants, and 72% for the Delta variant.

The effectiveness in preventing hospitalization or death after the first dose was reported as 79% for the Alpha variant, 89% for the Beta and Gamma variants, and 96% for the Delta variant.

Baek Gyeong-taek, Head of the Central Disease Control Headquarters Situation Management Team, stated at the COVID-19 regular briefing that "Currently, 63,248 healthcare workers in the country have received the Moderna vaccine," and added, "If symptoms suspected of myocarditis or pericarditis occur after receiving the Moderna vaccine, or if facial swelling appears in those who have had skin filler procedures, they should promptly seek medical attention."

Furthermore, starting from the 26th, Moderna vaccine administration will begin for people in their 50s. The supply of Moderna vaccines for the 50s age group is gradually arriving. On this day as well, 290,000 doses of the Moderna vaccine were delivered to the country, bringing the total doses introduced this month to 1.04 million. According to the Promotion Team, an additional 31 million doses are expected to be supplied by the end of August.

Kim Ki-nam, Head of the Vaccination Planning Division of the Promotion Team, said, "Additional Moderna vaccines are scheduled to be introduced in July," and added, "The total monthly quantity of Moderna vaccines and the schedule will be separately announced when confirmed."

This content was produced with the assistance of AI translation services.